Cas:1000340-58-8 4-Bromo-6-methyl-1H-pyrrolo[2,3-b]pyridine manufacturer & supplier

Chemical Name:4-Bromo-6-methyl-1H-pyrrolo[2,3-b]pyridine

CAS.NO:1000340-58-8

Synonyms:1H-Pyrrolo[2,3-b]pyridine, 4-bromo-6-methyl-;4-Bromo-6-methyl-7-azaindole;4-Bromo-6-methyl-1H-pyrrolo[2,3-b]pyridine;4-Bromo-6-methyl-7-azaindol

Molecular Formula:C₈H₇BrN₂

Molecular Weight:211.059

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.7±0.1 g/cm3

Index of Refraction:1.697

PSA:28.68000

Exact Mass:209.979248

LogP:2.95

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1H-Pyrrolo[2,3-b]pyridine, 4-bromo-6-methyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Bromo-6-methyl-7-azaindol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Bromo-6-methyl-7-azaindol Use and application,4-Bromo-6-methyl-1H-pyrrolo[2,3-b]pyridine technical grade,usp/ep/jp grade.

Related News: The Philippines, the United States and Australia have expanded travel restrictions, temporarily barring noncitizens who have recently traveled to China. 4-Bromo-6-methyl-1H-pyrrolo[2,3-b]pyridine manufacturer Also, states with higher obesity rates also tend to have higher rates of food insecurity, which means lower incomes in general,” she noted. “Bariatric surgery is an expensive proposition, especially if one does not have good insurance coverage for it. 4-Bromo-6-methyl-1H-pyrrolo[2,3-b]pyridine supplier Also, states with higher obesity rates also tend to have higher rates of food insecurity, which means lower incomes in general,” she noted. “Bariatric surgery is an expensive proposition, especially if one does not have good insurance coverage for it. 4-Bromo-6-methyl-1H-pyrrolo[2,3-b]pyridine vendor Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition. 4-Bromo-6-methyl-1H-pyrrolo[2,3-b]pyridine factory This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement.